DPYSL5 and Sensory neuropathy: Patients with serologic detection of anti-CV2 antibodies are more likely to present a clinical picture characterised by motor involvement and demyelination than those with anti-Hu antibodies [117]; nevertheless, paraneoplastic subacute sensory neuropathies could be seronegative in 16% of patients.